Transient expansion of vestibular schwannoma following stereotactic radiosurgery

被引:121
|
作者
Nagano, Osamu [1 ]
Higuchi, Yoshinori
Serizawa, Toru [3 ]
Ono, Junichi [2 ]
Matsuda, Shinji [4 ]
Yamakami, Iwao
Saeki, Naokatsu
机构
[1] Chiba Univ, Grad Sch Med, Dept Neurol Surg, Chuou Ku, Chiba 2600856, Japan
[2] Chiba Cardiovasc Ctr, Dept Neurosurg, Ichihara, Chiba, Japan
[3] Chiba Cardiovasc Ctr, Gamma Knife House, Ichihara, Chiba, Japan
[4] Chiba Cardiovasc Ctr, Dept Neurol, Ichihara, Chiba, Japan
关键词
facial nerve function; Gamma Knife surgery; stereotactic radiosurgery; transient tumor expansion; trigeminal nerve dysesthesia; vestibular schwannoma;
D O I
10.3171/JNS/2008/109/11/0811
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Object. The authors prospectively analyzed volume changes in vestibular schwannomas (VSs) after stereotactic radiosurgery. Methods. One hundred Consecutive patients with unilateral VS treated with Gamma Knife Surgery (GKS) at Chiba Cardiovascular Center between 1998 and 2006 were analyzed in this study. For each lesion the Gd-enhanced volume was measured serially every 3 months in the 1st year, then every 6 months thereafter, using volumetric software. The frequency and degree of transient tumor expansion were documented and possible prognostic factors were analyzed. Concurrently, neurological deterioration involving trigeminal, facial, and cochlear nerve functions were also assessed. Results. The mean observation period was 65 months (range 25-100 months). There were 32 men and 68 women whose mean age was 59.1 years (range 29-80 years). Tumor volumes at GKS averaged 2.7 cm(3) (range 0.1-13.2 C 113), and the lesions were irradiated at the mean 52.2% isodose line for the tumor margin (range 50-67%), with a mean dose of 12.2 Gy (range 10.5-13 Gy) at the periphery. The tumor Volume was increased by 23% at 3 months and 27% at 6 months. Tumors shrank to their initial size over a mean period of 12 months. The maximum volume increase was < 10% (no significant increase) in 26 patients, 10-30% in 23, 30-50% in 22, 50-100% in 16, and > 100% in 13. The peak tumor expansion averaged 47% (range 0-613%). A high-dose (>= 3.5 Gy/min) treatment appears to be the greatest risk factor for transient tumor expansion, although the difference did not reach statistical significance. Transient facial palsy and facial dysesthesia correlated strongly with tumor expansion, but only half of the hearing loss was coincident with this phenomenon. Conclusions. Transient expansion of VSs after GKS was found to be much more frequent than previously reported, strongly Suggesting a correlation with deterioration of facial and trigeminal nerve functions.
引用
收藏
页码:811 / 816
页数:6
相关论文
共 50 条
  • [31] Microsurgery of Vestibular Schwannoma Post-radiosurgery
    Misra, Basant Kumar
    Churi, Omkar N.
    NEUROLOGY INDIA, 2019, 67 (05) : 1274 - 1278
  • [32] De novo cavernous malformation arising in the wall of vestibular schwannoma following stereotactic radiosurgery: case report and review of the literature
    Nussbaum, Leslie A.
    Kallmes, Kevin M.
    Bellairs, Ellen
    McDonald, William
    Nussbaum, Eric S.
    ACTA NEUROCHIRURGICA, 2019, 161 (01) : 49 - 55
  • [33] De novo cavernous malformation arising in the wall of vestibular schwannoma following stereotactic radiosurgery: case report and review of the literature
    Leslie A. Nussbaum
    Kevin M. Kallmes
    Ellen Bellairs
    William McDonald
    Eric S. Nussbaum
    Acta Neurochirurgica, 2019, 161 : 49 - 55
  • [34] Long-Term Hearing Outcomes Following Stereotactic Radiosurgery in Vestibular Schwannoma Patients-A Retrospective Cohort Study
    Santa Maria, Peter L.
    Shi, Yangyang
    Gurgel, Richard K.
    Corrales, C. Eduardo
    Soltys, Scott G.
    Santa Maria, Chloe
    Murray, Kevin
    Chang, Steven D.
    Blevins, Nikolas H.
    Gibbs, Iris C.
    Jackler, Robert K.
    NEUROSURGERY, 2019, 85 (04) : 550 - 559
  • [35] Repeat single-fraction stereotactic radiosurgery for recurrent vestibular schwannoma
    Rapp, Cooper T.
    Amdur, Robert J.
    Bova, Frank J.
    Foote, Kelly D.
    Friedman, William A.
    REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2022, 27 (04) : 655 - 658
  • [36] Repeat stereotactic radiosurgery in vestibular schwannoma patients: A systematic review and meta-analysis
    Hajikarimloo, Bardia
    Habibi, Mohammad Amin
    Alvani, Mohammadamin Sabbagh
    Zare, Amir Hessam
    Tos, Salem M.
    Sheehan, Jason P.
    JOURNAL OF CLINICAL NEUROSCIENCE, 2024, 130
  • [37] Matched Comparison of Hearing Outcomes in Patients With Vestibular Schwannoma Treated With Stereotactic Radiosurgery or Observation
    Schnurman, Zane
    Gurewitz, Jason
    Smouha, Eric
    McMenomey, Sean O.
    Roland, J. Thomas, Jr.
    Golfinos, John G.
    Kondziolka, Douglas
    NEUROSURGERY, 2022, 91 (04) : 641 - 647
  • [38] Cochlea Radiation Dose Correlates with Hearing Loss After Stereotactic Radiosurgery of Vestibular Schwannoma
    Gephart, Melanie G. Hayden
    Hansasuta, Ake
    Balise, Raymond R.
    Choi, Clara
    Sakamoto, Gordon T.
    Venteicher, Andrew S.
    Soltys, Scott G.
    Gibbs, Iris C.
    Harsh, Griffith R.
    Adler, John R.
    Chang, Steven D.
    WORLD NEUROSURGERY, 2013, 80 (3-4) : 359 - 363
  • [39] High-grade glioma after stereotactic radiosurgery for vestibular schwannoma
    Aran-Echabe, Eduardo
    Cascallar Caneda, Luis
    Lobato Busto, Ramon
    Reyes Santias, Rosa Maria
    Varela Pazo, Ana
    Gelabert-Gonzalez, Miguel
    NEUROCIRUGIA, 2016, 27 (01): : 33 - 37
  • [40] Long-Term Outcomes of Stereotactic Radiosurgery for Trigeminal, Facial, and Jugular Foramen Schwannoma in Comparison with Vestibular Schwannoma
    Shinya, Yuki
    Hasegawa, Hirotaka
    Shin, Masahiro
    Sugiyama, Takehiro
    Kawashima, Mariko
    Katano, Atsuto
    Kashio, Akinori
    Kondo, Kenji
    Saito, Nobuhito
    CANCERS, 2021, 13 (05) : 1 - 12